MedTrace Logo

Assessment of Sleep Complaints in Brain Tumor Survivors

NCT01102998 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 153

Last updated 2013-11-18

No results posted yet for this study

Summary

Survivors of pediatric brain tumors are noted to have increased rates of excessive daytime sleepiness. However, very little data are available regarding the specific sleep disturbances of pediatric brain tumor survivors. Children ages 8 to 18 years of age who are at least 5 years from diagnosis and at least 2 years post treatment or observation only for a brain tumor will be targeted to assess the prevalence of sleep complaints.

The study focuses on the following objectives:

* To estimate sleep disturbance in a cohort of pediatric brain tumor survivors.
* Estimate the rates of parent- and self-reported excessive daytime sleepiness in pediatric brain tumors
* Estimate the rates of parent-reported sleep-disordered breathing, including snoring and witnessed apneas, in pediatric brain tumor survivors
* Estimate the rates of parent- and self-reported behavioral sleep problems, including nocturnal enuresis, bedtime resistance, nighttime awakenings, nightmares, and fatigue in pediatric brain tumor survivors.

The Study focuses on the following secondary objectives:

* To describe bedtime patterns and sleep hygiene of pediatric brain tumor survivors.
* Estimate the typical parent- and self-reported weekday sleep duration of pediatric brain tumor survivors
* Estimate the typical parent- and self-reported weekend sleep duration of pediatric brain tumor survivors and if it differs from the weekday sleep duration
* Estimate the typical parent- and self-reported consistency of sleep hygiene in pediatric brain tumor survivors

Conditions

Sponsors & Collaborators

Principal Investigators

  • Valerie Crabtree, Ph.D · St. Jude Children's Research Hospital

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2012-09-30
Completion
2013-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01102998 on ClinicalTrials.gov